Project Grant R44AR086679
Award Date 9/5/26
Completion Date 8/31/28
Dollars Obligated $1.3M
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cupertino, CA 95014, USA
Similar Awards
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded The Leland Stanford Junior University $667,829 on August 15, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop and validate an osteoinductive, biodegradable intramedullary implant as an adjunctive therapy for distraction osteogenesis in large orthopedic trauma and limb reconstruction. The project addresses a major limitation of the Ilizarov surgical technique—the...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded $1.696 million to Poly Orth International on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds translational pre-clinical research and development of a 3D-printed skin and bone integrated pylon (SBIP-3D) for direct skeletal attachment of limb prostheses. The technology, developed by Poly Orth International, integrates with both residual bone...
- The National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Penderia Technologies Inc. $306,722 on September 19, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to fabricate and characterize a distal femoral fracture fixation plate featuring an implantable, battery-free wireless sensor for intra- and postoperative monitoring of fixation plate strains. The project targets personalized postoperative...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded the University of Arizona $1,149,088 on September 19, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to refine a computational surgical decision tool for vertebral body tethering (VBT), a growth-modulating surgical technique for correcting pediatric spinal deformities. The project develops and validates a patient-specific computational model to predict which children...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant of $158,555 to the University of Pittsburgh under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop and validate a wireless metamaterial interbody fusion cage for real-time assessment of lumbar spinal fusion. The project, awarded September 1, 2025, with an ultimate completion date of August 31, 2027, addresses current limitations in wireless force...
- The National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Rush University Medical Center $643,185 on June 10, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds development of validated, patient-specific computational models to predict polyethylene wear in total shoulder arthroplasty (TSA) and identify modifiable surgical, design, and rehabilitation targets to improve implant...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded MDS II LLC $299,996 on September 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop and commercialize the Rotational Femoral Nail System (RFNS), an orthopedic device designed to prevent and correct rotational malalignment in femoral fractures. The RFNS integrates an adjustable rotational mechanism and goniometer to enable precise intraoperative alignment and...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Baylor College of Medicine $374,000 on August 17, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to investigate the role of the transcription factor TONEBP/NFAT5 in regulating chondrocyte energy availability and extracellular matrix synthesis during postnatal bone growth. The research examines how chondrocytes balance intense matrix production with protein quality...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Northstar Genomics, LLC $286,415 on September 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The Phase 1 research project aims to enhance the efficiency of generating human skeletal muscle in pigs for reconstructive and transplantation-based surgeries to treat skeletal muscle loss from trauma, surgery, and deep burns. The recipient's current approach uses somatic...
- This $672,394.58 project grant from the National Institutes of Health's National Institute of Dental and Craniofacial Research Oral Diseases and Disorders Research program (CFDA 93.121) supports the development of a crosslinkable tissue particle implant for regenerating craniofacial bone. Led by Leefa Biotech LLC, the one-year award aims to demonstrate improved bone regeneration in critical-size cranial bone defects using the implant compared to the current standard of care. If successful, the...